World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
62
Citations
20554
World Ranking
3095
National Ranking
135

Thierry Walzer publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Thierry Walzer sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 183 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Thierry Walzer D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Thierry Walzer sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 62 D-Index — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Thierry Walzer is affiliated with Claude Bernard University Lyon 1 in France. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a particular focus on Immunology as well as subfields including Infectious Diseases, Molecular Biology, Oncology, and Hematology.

The scientist's scholarly output includes numerous publications across several topics, notably:

  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • IL-33, ST2, and ILC Pathways
  • Immunodeficiency and Autoimmune Disorders
  • CAR-T cell therapy research

Walzer's recent papers cover various aspects of immunology and infectious diseases, with a marked emphasis on COVID-19 and immune response mechanisms. Selected recent publications include:

  • "Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions," 2020, published in Autoimmunity Reviews
  • "A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity," 2021, published in Cellular and Molecular Immunology
  • "Type I IFN immunoprofiling in COVID-19 patients," 2020, published in Journal of Allergy and Clinical Immunology
  • "Immunogenicity and efficacy of heterologous ChAdOx1-BNT162b2 vaccination," 2021, published in Nature
  • "Polyclonal expansion of TCR Vβ 21.3 + CD4 + and CD8 + T cells is a hallmark of multisystem inflammatory syndrome in children," 2021, published in Science Immunology

The scientist collaborates frequently with several coauthors, including Alexandre Bélot, Marine Villard, Sébastien Viel, Sophie Trouillet-Assant, and Antoine Marçais.

Walzer's research has been featured extensively in multiple publication venues, notably:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Journal of Experimental Medicine
  • European Journal of Immunology
  • Nature Communications
  • Cellular and Molecular Immunology

Best Publications

  • Functions of natural killer cells

    Eric Vivier;Elena Tomasello;Elena Tomasello;Myriam Baratin;Myriam Baratin;Thierry Walzer;Thierry Walzer

  • Natural-killer cells and dendritic cells: “l'union fait la force”

    Thierry Walzer;Marc Dalod;Marc Dalod;Scott H. Robbins;Scott H. Robbins;Laurence Zitvogel;Laurence Zitvogel

  • Maturation of mouse NK cells is a 4-stage developmental program.

    Laura Chiossone;Julie Chaix;Julie Chaix;Nicolas Fuseri;Claude Roth

  • The trafficking of natural killer cells

    Claude Grégoire;Lionel Chasson;Lionel Chasson;Carmelo Luci;Carmelo Luci;Elena Tomasello;Elena Tomasello

  • Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions.

    Yvan Jamilloux;Yvan Jamilloux;Thomas Henry;Alexandre Belot;Sébastien Viel

  • TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway

    Sébastien Viel;Antoine Marçais;Fernando Souza Fonseca Guimaraes;Fernando Souza Fonseca Guimaraes;Roisin Loftus

  • Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling

    Scott H Robbins;Thierry Walzer;Thierry Walzer;Doulaye Dembélé;Christelle Thibault

  • The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells

    Antoine Marçais;Julien Cherfils-Vicini;Charlotte Viant;Sophie Degouve

  • T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow

    Cécile Daussy;Fabrice Faure;Katia Mayol;Sébastien Viel

  • Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46

    Thierry Walzer;Mathieu Bléry;Julie Chaix;Nicolas Fuseri

  • Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor

    Thierry Walzer;Laura Chiossone;Julie Chaix;Andrew Calver

  • Cutting Edge: Priming of NK Cells by IL-18

    Julie Chaix;Marlowe S. Tessmer;Kasper Hoebe;Nicolas Fuséri

  • Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor

    Emilie Narni-Mancinelli;Julie Chaix;Aurore Fenis;Yann M. Kerdiles

  • A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity.

    Vincent Legros;Vincent Legros;Solène Denolly;Manon Vogrig;Bertrand Boson

  • Adipose-Resident Group 1 Innate Lymphoid Cells Promote Obesity-Associated Insulin Resistance

    Timothy E. O'Sullivan;Moritz Rapp;Xiying Fan;Orr El Weizman

  • Type I IFN immunoprofiling in COVID-19 patients.

    Sophie Trouillet-Assant;Sophie Trouillet-Assant;Sebastien Viel;Alexandre Gaymard;Sylvie Pons

  • Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children

    Marie-Louise Frémond;Marie-Louise Frémond;Marie-Louise Frémond;Mathieu Paul Rodero;Mathieu Paul Rodero;Nadia Jeremiah;Alexandre Belot

  • Nectin-like protein 2 defines a subset of T-cell zone dendritic cells and is a ligand for class-I-restricted T-cell-associated molecule.

    Laurent Galibert;Geoffrey S. Diemer;Zhi Liu;Richard S. Johnson

  • Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells

    Sophie Ugolini;Christophe Arpin;Nicolas Anfossi;Thierry Walzer

  • Immunogenicity and efficacy of heterologous ChadOx1/BNT162b2 vaccination.

    Bruno Pozzetto;Vincent Legros;Vincent Legros;Sophia Djebali;Véronique Barateau

  • Natural killer cells: from CD3(-)NKp46(+) to post-genomics meta-analyses.

    Thierry Walzer;Sébastien Jaeger;Sébastien Jaeger;Julie Chaix;Julie Chaix;Eric Vivier

Frequent Co-Authors

Eric Vivier
Eric Vivier Aix-Marseille University
Jacques Bienvenu
Jacques Bienvenu Claude Bernard University Lyon 1
Thomas Henry
Thomas Henry Claude Bernard University Lyon 1
Yanick J. Crow
Yanick J. Crow Université Paris Cité
Marc Dalod
Marc Dalod Centre d’Immunologie de Marseille-Luminy
Immo Prinz
Immo Prinz Hannover Medical School
Gillian I. Rice
Gillian I. Rice University of Manchester
Capucine Picard
Capucine Picard Université Paris Cité
Elena Tomasello
Elena Tomasello Aix-Marseille University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields can broaden career opportunities. Many students consider nursing pathways such as becoming a Nurse Practitioner (NP), which offer hands-on roles in patient care and research support. If you are looking for flexible educational options, programs like the what is the easiest np program can provide insight into selecting a manageable yet comprehensive curriculum.

Specializing further into mental health, the Psychiatric-Mental Health Nurse Practitioner (PMHNP) pathway is growing rapidly. Finding quality programs is essential, and the top online pmhnp programs are noted for their excellent clinical placement rates, a crucial factor for gaining practical experience.

Cost is often a major concern when pursuing advanced degrees. For budget-conscious students, exploring the cheapest pmhnp programs online can help reduce financial strain while still receiving accredited education.

Additionally, understanding the financial outlook is important when planning your career. Transparent data on salaries such as the dnp salary transparency offers valuable information about earning potential, helping students align their educational investments with career goals.

Best Scientists Citing Thierry Walzer

Trending Scientists

Recently Published Articles